<!DOCTYPE html>
<html>
<head>
  <title>Side effects and safety of Metronidazole </title>
  <meta charset="utf-8">
  <meta name="description" content="Side effects and safety of Metronidazole ">
  <meta name="author" content="Chaochen Wang$^1$, Yingsong Lin$^1$, Masumi Okuda$^2$, Shogo Kikuchi$^1$">
  <meta name="generator" content="slidify" />
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta http-equiv="X-UA-Compatible" content="chrome=1">
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/default.css" media="all" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/phone.css" 
    media="only screen and (max-device-width: 480px)" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/slidify.css" >
  <link rel="stylesheet" href="libraries/highlighters/highlight.js/css/solarized_light.css" />
  <base target="_blank"> <!-- This amazingness opens all links in a new tab. -->  <link rel=stylesheet href="libraries/widgets/quiz/css/demo.css"></link>
<link rel=stylesheet href="libraries/widgets/bootstrap/css/bootstrap.css"></link>
<link rel=stylesheet href="libraries/widgets/interactive/css/aceeditor.css"></link>
<link rel=stylesheet href="./assets/css/ribbons.css"></link>
<link rel=stylesheet href="./assets/css/style.css"></link>

  
  <!-- Grab CDN jQuery, fall back to local if offline -->
  <script src="http://ajax.aspnetcdn.com/ajax/jQuery/jquery-1.7.min.js"></script>
  <script>window.jQuery || document.write('<script src="libraries/widgets/quiz/js/jquery.js"><\/script>')</script> 
  <script data-main="libraries/frameworks/io2012/js/slides" 
    src="libraries/frameworks/io2012/js/require-1.0.8.min.js">
  </script>
  
  

</head>
<body style="opacity: 0">
  <slides class="layout-widescreen">
    
    <!-- LOGO SLIDE -->
      <slide class="nobackground">
    <article class="flexbox vcenter">
      <span>
        <img width='300px' src="assets/img/logo.png">
      </span>
    </article>
  </slide>
    <slide class="title-slide segue nobackground">
  <hgroup class="auto-fadein">
    <h1>Side effects and safety of Metronidazole </h1>
    <h2></h2>
    <p>Chaochen Wang$^1$, Yingsong Lin$^1$, Masumi Okuda$^2$, Shogo Kikuchi$^1$<br/>1.Aichi Medical University School of Medicine 2. Hyogo College of Medicine</p>
  </hgroup>
  <article></article>  
</slide>
    

    <!-- SLIDES -->
    <slide class="class" id="id" style="background:;">
  <article data-timings="">
    <style type="text/css">
body {background:grey transparent;
}
A:link {
 COLOR: #AA0000 /*The color of the link*/
}
A:visited {
 COLOR: #800080 /*The color of the visited link*/
}
A:hover {
 COLOR: #AA0000 /*The color of the mouseover or 'hover' link*/
}
BODY { COLOR: #800080 /*The color of all the other text within the body of the page*/
}
</style>

<h2>Background</h2>

<blockquote>
<p>MNZ was categorized as <strong>Possibly carcinogenic to human (2B)</strong> </p>

<p><cite><a href="http://monographs.iarc.fr/ENG/Monographs/suppl7/index.php">by International Agency for Research on Cancer, IARC in 1987</a></cite></p>
</blockquote>

<ul>
<li><p><strong>Metronidazole (MNZ)</strong> has been broadly prescribed as therapy for \(H. pylori\) eradication worldwide. </p></li>
<li><p>Second line regimen using MNZ is covered under national health insurance in Japan.</p></li>
<li><p>Proton pump inhibitor (PPI) + Amoxicillin (AMPC) + Clarithromycin (CLA), (PAC) regimen had a significant lower <strong>eradication rate</strong> of 60.5\(\%\) compared with PPI + AMPC + MNZ, (PAM) regimen (98.3\(\%\)).<sup>1</sup> </p></li>
<li><p>Resistance rate of CLA in Japanese children is reported to be more than 40\(\%\).<sup>2</sup></p></li>
</ul>

<p><br>
<br>
1: Unpublished data, Mabe et al.; 2: <a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1442-200X.2009.02915.x/abstract">Kato and Fujimura 2010</a></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="class" id="id" style="background:;">
  <hgroup>
    <h2>Pubmed searching</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><p>Related literature (published until April. 2016) were reviewed. </p></li>
<li><p>Search term:<br>
((&quot;Drug-Related Side Effects and Adverse Reactions&quot;[Mesh]) AND &quot;Metronidazole&quot;[Mesh]) <br> OR <br> ( &quot;Metronidazole/adverse effects&quot;[Mesh] OR &quot;Metronidazole/toxicity&quot;[Mesh] ) <br> OR <br>  ((&quot;Metronidazole&quot;[Mesh]) AND &quot;Carcinogenicity Tests&quot;[Mesh])</p></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-3" style="background:;">
  <hgroup>
    <h2>Evidence found</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>Oral exposure of MNZ has shown carcinogenic activity in mice and rats.</strong></p>

<table><thead>
<tr>
<th align="center"></th>
<th align="right">Results</th>
<th align="right">Year</th>
<th align="center">Authors</th>
</tr>
</thead><tbody>
<tr>
<td align="center"><em>Carcinogenic cites:</em></td>
<td align="right"></td>
<td align="right"></td>
<td align="center"></td>
</tr>
<tr>
<td align="center"><strong>Pulmonary</strong></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1972</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/5058971">Rustia and Shubik</a></td>
</tr>
<tr>
<td align="center"></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1977</td>
<td align="center"><a href="http://www.inchem.org/documents/iarc/vol13/metronidazole.html">IARC</a></td>
</tr>
<tr>
<td align="center"></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1983</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cavaliere+1983%2C+metronidazole">Cavaliere <em>et al.</em></a></td>
</tr>
<tr>
<td align="center"><strong>Liver</strong></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1979</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/288941">Rustia and Shubik</a></td>
</tr>
<tr>
<td align="center"><strong>Lymphomas</strong></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1972</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/5058971">Rustia and Shubik</a></td>
</tr>
<tr>
<td align="center"><strong>Mammary-gland</strong></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1979</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/288941">Rustia and Shubik</a></td>
</tr>
<tr>
<td align="center"></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1984</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cavaliere+1984%2C+metronidazole">Cavaliere <em>et al.</em></a></td>
</tr>
<tr>
<td align="center"><strong>Pituitary-gland</strong></td>
<td align="right">\(\uparrow\)</td>
<td align="right">1979</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pubmed/288941">Rustia and Shubik</a></td>
</tr>
<tr>
<td align="center"><em>Genetic damage</em></td>
<td align="right">\(\bigotimes\)</td>
<td align="right">2000</td>
<td align="center"><a href="http://jac.oxfordjournals.org/content/46/6/987.long">Touati <em>et al</em></a></td>
</tr>
<tr>
<td align="center"><em>Reproductive Orgains <br> &amp; Fertility</em></td>
<td align="right">\(\downarrow\)</td>
<td align="right">2013</td>
<td align="center"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914484/">Kumari and Singh</a></td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue" id="slide-4" style="background:black;">
  <hgroup>
    <h1>However, not in humans</h1>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-5" style="background:;">
  <article data-timings="">
    <p><a href="http://www.nejm.org/doi/full/10.1056/NEJM197909063011003">Lack of evidence for cancer due to use of metronidazole. N Engl J Med. 1979;301:519â€“522.</a></p>

<div class="centered">
<IMG SRC="NEJM.png" style="width:900px;height:550px">
</div>

<hr>

<h2>Other cancer studies in Humans</h2>

<ul>
<li><p>Data on MNZ carcinogenecity for humans is still not sufficient. </p></li>
<li><p>No increased cancer risk in 12,000 users of MNZ.<sup>1</sup> \(\Longrightarrow\) Only followed for 2.5 years. (A letter to JAMA)</p></li>
<li><p>No association between short-term exposure to MNZ and cancer in human were found in 5,222 MNZ user/nonuser pairs <strong>(RR 0.98; 95% CI, 0.80$-$1.20)</strong><sup>2</sup></p></li>
<li><p>Another retrospective study<sup>3</sup> of children (\(<\) 5 \(y.\), <em>n</em> \(=\) 328,846) who had been exposed to MNZ in utero also reported <strong>negative results (RR 0.81; 95% CI, 0.41$-$1.59)</strong> on cancer incidence of all sites. </p></li>
</ul>

<p><br><br></p>

<ol>
<li><a href="http://jama.jamanetwork.com/article.aspx?articleid=372448">Danielson 1982</a>; 2.<a href="http://cid.oxfordjournals.org/content/26/2/384.short">Falagas <em>et al.</em> 1998</a>; 3. <a href="http://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291097-0142%2819981001%2983:7%3C1461::AID-CNCR25%3E3.0.CO;2-1/abstract">Thapa <em>et al.</em> 1998</a></li>
</ol>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-6" style="background:;">
  <hgroup>
    <h2>Other potential (very rare) side effects</h2>
  </hgroup>
  <article data-timings="">
    <ol>
<li>Brain/nerve related: seizures<sup>1</sup> , aseptic meningitis<sup>2</sup> , encephalopathy<sup>3</sup> .<br> \(\Longrightarrow\) Prolonged use of MNZ. </li>
<li>Gastrointestinal tract related: nausea, occasionally vomiting, diarrhea.<sup>4</sup> <br> \(\Longrightarrow\) Daily dose \(\geq\) 2250 mg.</li>
<li>Skin eruption<sup>5</sup> , pancreatitis<sup>6</sup> .</li>
</ol>

<ul>
<li><strong>Drug-drug interaction:</strong>

<ul>
<li>\(\uparrow\) the effect of warfarin.</li>
<li>\(\downarrow\) the function of ALDH2. </li>
</ul></li>
</ul>

<p><br><br>
1. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696306/">Hari <em>et al.</em> 2013</a>; 2. <a href="http://www.nejm.org/doi/full/10.1056/NEJMicm1505174">Farmakiotis <em>et al.</em> 2016</a>; 3. <a href="http://annals.org/article.aspx?articleid=659104&amp;resultClick=3">Khan <em>et al.</em>, 2007</a>;4. <a href="http://www.sciencedirect.com/science/article/pii/S1383576914000725">Ohnishi <em>et al.</em> 2014</a>;5. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830266/">Kumar <em>et al.</em> 2013</a>;6. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939404/">Oâ€™Halloran <em>et al.</em> 2010</a>.</p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-7" style="background:;">
  <article data-timings="">
    <p>Recommended regimens in <a href="https://www.evidence.nhs.uk/formulary/bnfc/current/1-gastro-intestinal-system/13-antisecretory-drugs-and-mucosal-protectants/helicobacter-pylori-infection">UK</a> </p>

<table><thead>
<tr>
<th></th>
<th align="center"></th>
<th align="center">Age Range (\(y.\))</th>
<th align="center">Oral dose (mg per day)<br> with omeprazole (PPI)</th>
<th align="right">combined with</th>
</tr>
</thead><tbody>
<tr>
<td></td>
<td align="center">AMPC</td>
<td align="center">\(1\sim 6\)</td>
<td align="center">250, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">125, 3 times</td>
<td align="right">MNZ</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center">\(6\sim 12\)</td>
<td align="center">500, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">250, 3 times</td>
<td align="right">MNZ</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center">\(12\sim18\)</td>
<td align="center">1000, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">500, 3 times</td>
<td align="right">MNZ</td>
</tr>
<tr>
<td></td>
<td align="center">CLA</td>
<td align="center">\(1\sim12\)</td>
<td align="center">7.5Â mg/kg (max. 500), twice</td>
<td align="right">MNZ/AMPC</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center">\(12\sim18\)</td>
<td align="center">500, twice</td>
<td align="right">MNZ/AMPC</td>
</tr>
<tr>
<td></td>
<td align="center">MNZ</td>
<td align="center">\(1\sim 6\)</td>
<td align="center">100, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">100, 3 times</td>
<td align="right">AMPC</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center">\(6\sim 12\)</td>
<td align="center">200, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">200, 3 times</td>
<td align="right">AMPC</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center">\(12\sim18\)</td>
<td align="center">400, twice</td>
<td align="right">CLA</td>
</tr>
<tr>
<td></td>
<td align="center"></td>
<td align="center"></td>
<td align="center">400, 3 times</td>
<td align="right">AMPC</td>
</tr>
</tbody></table>

<p>Abbreviations: AMPC, amoxicillin; CLA, clarithromycin; MNZ, metronidazole.</p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-8" style="background:;">
  <article data-timings="">
    <p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21558964">Evidence-based guidelines from <strong>ESPGHAN</strong> and <strong>NASPGHAN</strong> for <em>Helicobacter pylori</em> infection in children. J Pediatr Gastroenterol Nutr. 2011;53:230â€“243.</a></p>

<div class="centered">
<IMG SRC="Guideline.png" style="width:850px;height:550px">
</div>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-9" style="background:;">
  <hgroup>
    <h2>Conclusion</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><p>So far, there is <strong>no convincing evidence</strong> that short-term exposure to metronidazole would increase the risk of any cancer in human. </p></li>
<li><p>Considering the high resistance rate of clarithromycin in Japanese children, first-line therapy recommendation of PPI+amoxicillin+metronidazole would be acceptable. </p></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

    <slide class="backdrop"></slide>
  </slides>
  <div class="pagination pagination-small" id='io2012-ptoc' style="display:none;">
    <ul>
      <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=1 title='NA'>
         1
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=2 title='Pubmed searching'>
         2
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=3 title='Evidence found'>
         3
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=4 title='However, not in humans'>
         4
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=5 title='NA'>
         5
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=6 title='Other potential (very rare) side effects'>
         6
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=7 title='NA'>
         7
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=8 title='NA'>
         8
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=9 title='Conclusion'>
         9
      </a>
    </li>
  </ul>
  </div>  <!--[if IE]>
    <script 
      src="http://ajax.googleapis.com/ajax/libs/chrome-frame/1/CFInstall.min.js">  
    </script>
    <script>CFInstall.check({mode: 'overlay'});</script>
  <![endif]-->
</body>
  <!-- Load Javascripts for Widgets -->
  <script src="libraries/widgets/quiz/js/jquery.quiz.js"></script>
<script src="libraries/widgets/quiz/js/mustache.min.js"></script>
<script src="libraries/widgets/quiz/js/quiz-app.js"></script>
<script src="libraries/widgets/bootstrap/js/bootstrap.min.js"></script>
<script src="libraries/widgets/bootstrap/js/bootbox.min.js"></script>
<script src="libraries/widgets/interactive/js/ace/js/ace.js"></script>
<script src="libraries/widgets/interactive/js/opencpu-0.5.js"></script>
<script src="libraries/widgets/interactive/js/interactive.js"></script>

  <!-- MathJax: Fall back to local if CDN offline but local image fonts are not supported (saves >100MB) -->
  <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        inlineMath: [['$','$'], ['\\(','\\)']],
        processEscapes: true
      }
    });
  </script>
  <script type="text/javascript" src="http://cdn.mathjax.org/mathjax/2.0-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
  <!-- <script src="https://c328740.ssl.cf1.rackcdn.com/mathjax/2.0-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
  </script> -->
  <script>window.MathJax || document.write('<script type="text/x-mathjax-config">MathJax.Hub.Config({"HTML-CSS":{imageFont:null}});<\/script><script src="libraries/widgets/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"><\/script>')
</script>
<script>  
  $(function (){ 
    $("#example").popover(); 
    $("[rel='tooltip']").tooltip(); 
  });  
  </script>  
  <!-- LOAD HIGHLIGHTER JS FILES -->
  <script src="libraries/highlighters/highlight.js/highlight.pack.js"></script>
  <script>hljs.initHighlightingOnLoad();</script>
  <!-- DONE LOADING HIGHLIGHTER JS FILES -->
   
  </html>